Texas 2021 87th Regular

Texas Senate Bill SB1161 Introduced / Bill

Filed 03/08/2021

                    2021S0161-1 03/05/21
 By: Schwertner, Buckingham S.B. No. 1161


 A BILL TO BE ENTITLED
 AN ACT
 relating to patient choice in the dispensing of
 clinician-administered drugs.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Subchapter A, Chapter 1369, Insurance Code, is
 amended by adding Section 1369.0042 to read as follows:
 Sec. 1369.0042.  PROHIBITION AGAINST LIMITING PATIENT
 CHOICE WITH CLINICIAN-ADMINISTERED DRUGS. (a) In this section:
 (1)  "Administer" means to directly apply a drug to the
 body of a patient by injection, inhalation, ingestion, or any other
 means.
 (2)  "Clinician-administered drug" means an outpatient
 prescription drug other than a vaccine that:
 (A)  cannot reasonably be self-administered by
 the patient to whom the drug is prescribed or by an individual
 assisting the patient with the self-administration; and
 (B)  is typically administered:
 (i)  by a physician or other health care
 provider authorized under the laws of this state to administer the
 drug, including when acting under a physician's delegation and
 supervision; and
 (ii)  in a physician's office, hospital
 outpatient infusion center, or other clinical setting.
 (3)  "Physician" means an individual licensed to
 practice medicine in this state.
 (4)  "Health care provider" means an individual who is
 licensed, certified, or otherwise authorized to provide health care
 services in this state.
 (b)  An individual or group accident and health insurance
 policy, contract, or agreement governed by the laws of this state
 may not:
 (1)  require clinician-administered drugs to be
 dispensed by a pharmacy selected by the health plan;
 (2)  if a clinician-administered drug is otherwise
 covered, limit or exclude coverage for such drugs when not
 dispensed by a pharmacy selected by the health plan;
 (3)  reimburse at a lesser amount
 clinician-administered drugs dispensed by a pharmacy not selected
 by the health plan; or
 (4)  require that an enrollee covered under such a
 policy, contract, or agreement pay an additional fee, higher copay,
 higher coinsurance, second copay, second coinsurance, or any other
 form of price increase for clinician-administered drugs when not
 dispensed by a pharmacy selected by the health plan.
 (c)  Nothing in this section may be construed as:
 (1)  authorizing a person to administer a drug when
 otherwise prohibited under the laws of this state or federal law; or
 (2)  modifying drug administration requirements under
 the laws of this state, including any requirements related to
 delegation and supervision of drug administration.
 SECTION 2.  This Act takes effect September 1, 2021.